16 Jun. 2010
WILMINGTON, N.C. (June 16, 2010) - PPD, Inc. (Nasdaq: PPDI) today announced it has been named Best Contract Research Organization (CRO) in Asia at the World Vaccine Congress' inaugural 2010 Vaccine Industry Excellence (ViE) Asia Awards held in Singapore on June 9. The award recognizes PPD's quality of services provided in Asia and its long-standing client partnerships in the vaccine industry.
"Our large presence in China and strong expertise in vaccine clinical research well position us to advance our clients' vaccine research and development programs and address unique requirements for managing vaccine studies in Asia," said Simon Britton, PPD's vice president of clinical development for Asia Pacific. "We are pleased the World Vaccine Congress has recognized our client relationships and investments in the growing vaccine industry."
PPD has delivered full-service, global vaccine development services to biopharmaceutical companies and government and nongovernment organizations for more than 20 years. In April, the company opened a vaccine clinical research center at the Taizhou China Medical City in Taizhou, China, further strengthening its clinical research and development services in one of the country's major regions for conducting vaccine studies. Through the center, PPD provides clinical monitoring services to companies seeking to develop vaccines in China.
PPD also launched its Vaccines & Biologics Center of Excellence earlier this year, which is a first-in-kind comprehensive network of integrated, world-class laboratory services focused on vaccine and biologic drug development. The center advances PPD's position as the industry leader in providing testing services for vaccines and other biologics with state-of-the-art facilities, processes and instrumentation to help clients realize the highest scientific standards and cost efficiencies for their programs.